Anemia of Inflammation: How Chronic Inflammation Causes Low Iron

Anemia means the blood carries too few healthy red blood cells or too little hemoglobin, the protein that ferries oxygen from the lungs to the tissues. The most familiar cause is iron deficiency, where the body simply lacks enough iron, often from blood loss or poor intake. But there is another major category, historically called anemia of chronic disease and now more precisely termed anemia of inflammation, in which the body actually has iron but cannot use it properly.

This form of anemia appears alongside many conditions marked by persistent inflammation, including autoimmune diseases, chronic infections, kidney disease, and cancer. What makes it distinctive is that the anemia is not a failure of iron supply so much as a consequence of how the immune system reorganizes iron handling during inflammation. Understanding that shift reveals why iron supplements alone often do not fix it, and why the underlying inflammation is the real target.

Hepcidin: The Master Switch That Locks Away Iron

The hormone at the center. Iron balance in the body is governed largely by a small hormone called hepcidin, produced by the liver. Hepcidin controls how much iron enters the bloodstream by regulating a protein called ferroportin, the channel that lets iron out of the cells that absorb and store it. When hepcidin is high, it causes ferroportin to be removed, effectively shutting the gates and keeping iron locked inside cells rather than circulating where the bone marrow can use it.

Inflammation raises hepcidin. The crucial link is that inflammation strongly stimulates hepcidin production. The inflammatory cytokine IL-6, in particular, signals the liver to make more hepcidin. From an evolutionary standpoint this may be a defense mechanism, since many invading microbes need iron to grow, and withholding iron can help starve them. But when inflammation is chronic rather than a brief response to infection, this iron-withholding response persists, and the ongoing shortage of usable iron becomes a problem in its own right.

Iron gets trapped, not lost. The result is a peculiar situation in which the body may hold plenty of iron overall, but that iron is sequestered inside macrophages and liver cells and cannot reach the developing red blood cells in the bone marrow. The marrow, starved of the iron it needs, cannot keep up with normal red cell production. This is why anemia of inflammation is sometimes described as a state of functional iron deficiency: the iron exists, but it is functionally unavailable.

More than one mechanism at work. Hepcidin-driven iron restriction is the central mechanism, but inflammation dampens red blood cell production in other ways too. Inflammatory cytokines can blunt the bone marrow's response to erythropoietin, the hormone that signals the marrow to produce red cells, so even a normal erythropoietin level may not translate into adequate output. Inflammation can also shorten the lifespan of circulating red blood cells, meaning they are cleared a little faster than usual. These effects compound the iron restriction, which is why the anemia can develop even when someone is eating plenty of iron-rich food.

Reading the Blood: Why Ferritin Can Mislead

Ferritin tells a complicated story. Ferritin is the protein that stores iron inside cells, and blood ferritin usually reflects the body's iron reserves. In straightforward iron deficiency, ferritin is low, signaling depleted stores. But ferritin is also an acute-phase protein, meaning it rises during inflammation regardless of iron status. So in anemia of inflammation, ferritin is often normal or even elevated, which can mask a true shortage of usable iron and complicate interpretation.

The classic laboratory pattern. The combination that points toward anemia of inflammation is low serum iron and low transferrin saturation, meaning little iron is circulating and available, together with normal or high ferritin, indicating that stored iron is not actually depleted. This differs from pure iron deficiency, where both circulating iron and stored iron are low. Recognizing this pattern helps clinicians distinguish between an anemia that needs more iron and one that needs the inflammation addressed.

Where CRP fits in. Because anemia of inflammation is fundamentally driven by an inflammatory state, markers of inflammation are informative context. C-reactive protein, which rises through the same IL-6 pathway that elevates hepcidin, offers a readout of whether significant inflammation is present. An elevated CRP alongside the iron pattern above supports the idea that inflammation, rather than iron supply, is at the heart of the anemia. Interpreting these values together is best done with a healthcare provider, and understanding what CRP numbers actually mean helps put any single reading in perspective.

The Conditions Behind Anemia of Inflammation

Autoimmune and inflammatory diseases. Conditions such as rheumatoid arthritis, inflammatory bowel disease, and other autoimmune diseases generate sustained inflammatory signaling that keeps hepcidin elevated. Anemia is a common companion to these diseases, and its severity often tracks with how active the underlying inflammation is. When the inflammatory disease flares, the anemia frequently worsens; when the disease is well controlled, the anemia often improves.

Chronic infections and kidney disease. Long-standing infections keep the immune system activated and hepcidin high, producing the same iron-restricted anemia. Chronic kidney disease adds another layer, because the kidneys normally produce erythropoietin, the hormone that tells the marrow to make red cells. Reduced erythropoietin combined with the inflammatory iron restriction common in kidney disease makes anemia especially frequent in that setting.

Obesity and low-grade inflammation. Even without a distinct disease, chronic low-grade inflammation can nudge iron handling in this direction. Obesity is associated with elevated IL-6 and hepcidin, and some people with obesity show signs of impaired iron availability despite adequate iron intake. This illustrates how the same hepcidin-driven mechanism operates across a spectrum, from overt chronic disease to the subtler inflammation of metabolic dysfunction.

When two causes overlap. Complicating matters, some people have both true iron deficiency and anemia of inflammation at the same time. This is common in conditions like inflammatory bowel disease, where chronic inflammation raises hepcidin while intestinal bleeding and poor absorption simultaneously drain iron stores. In these mixed situations the laboratory picture can be genuinely confusing, since inflammation pushes ferritin up while the coexisting deficiency pulls it down. Untangling these overlapping causes usually requires careful evaluation and sometimes additional testing, underscoring why anemia should not be self-diagnosed from a single value.

Addressing the Root: Calming Inflammation

Treat the underlying condition. Because anemia of inflammation stems from an inflammatory state, the most effective approach is to control whatever is driving the inflammation. When an autoimmune disease is brought into remission or an infection is resolved, hepcidin falls, the iron gates reopen, and red cell production can recover. This is why simply adding iron often fails: if hepcidin stays high, much of the extra oral iron is absorbed poorly or promptly locked away.

Lifestyle factors that lower inflammation. For the low-grade inflammation that accompanies metabolic conditions, the same measures that reduce systemic inflammation may help ease its downstream effects on iron. An anti-inflammatory dietary pattern, regular physical activity, adequate sleep, and stress management all tend to lower inflammatory signaling. Reducing that signaling can, over time, take some of the pressure off the hepcidin system that restricts iron.

Working with a healthcare provider. Anemia always warrants proper medical evaluation, because its causes range from benign to serious and because the right treatment depends entirely on the cause. Iron supplements, intravenous iron, or other therapies may be appropriate in some cases, but only after the type of anemia is correctly identified. Self-treating with iron can be counterproductive or even harmful when inflammation, not iron shortage, is the true problem.

Nutrition still matters. Even though extra iron alone rarely resolves anemia of inflammation, a nourishing diet remains important, because the marrow needs a full complement of building blocks to make red cells, including protein, folate, and vitamin B12 alongside iron. In practice, an eating pattern that supports iron and vitamin needs while also being broadly anti-inflammatory serves both goals at once. This is not about megadoses of any single nutrient but about steady, adequate intake that supports blood production without adding to the inflammatory burden that restricts iron in the first place.

The value of watching inflammation. For someone managing a chronic inflammatory condition, keeping an eye on an inflammatory marker like CRP can add useful context to the broader clinical picture. A trend over time reflects how well the underlying inflammation is being controlled, which is precisely the factor that governs this kind of anemia. Shared with a healthcare provider, that information can help connect changes in inflammation to changes in iron and blood counts.